|
|
||||||||
The Journal of Immunology, Vol 145, Issue 10 3256-3261, Copyright © 1990 by American Association of Immunologists
ARTICLES |
V Praloran, C Raventos-Suarez, A Bartocci, J Lucas, ER Stanley and JJ Gibbons Jr
Department of Developmental Biology and Cancer, Albert Einstein College of Medicine, Bronx, NY 10461.
During the course of an acute graft-vs-host reaction in the mouse we observed a progressive increase in the concentration of CSF-1 in serum and liver, peaking at day 14. In contrast, there was a progressive decrease in the splenic CSF-1 concentration. In vivo studies of 125I- CSF-1 uptake and degradation and in vitro studies of 125I-CSF-1 binding by splenic cells demonstrated that within 24 h of the reaction the number of CSF-1 receptor+ cells had increased by 2-fold and their capacity to express the CSF-1 receptor by approximately 3-fold, resulting in a approximately 2.5-fold increase in the splenic clearance of CSF-1 from the circulation. Inasmuch as at 24 h, serum CSF-1 was not significantly altered, these results are suggestive of an increased rate of release of CSF-1 into the circulation early in the response. The splenic CSF-1-receptor bearing cells were in a Mac-1+ fraction that is consistent with a role for CSF-1 in the generation of host-derived splenic macrophages in acute graft-vs-host reaction.
This article has been cited by other articles:
![]() |
Y. Le Meur, V. Leprivey-Lorgeot, S. Mons, M. Jose, J. Dantal, B. Lemauff, J.-C. Aldigier, C. Leroux-Robert, and V. Praloran Serum levels of macrophage-colony stimulating factor (M-CSF): a marker of kidney allograft rejection Nephrol. Dial. Transplant., July 1, 2004; 19(7): 1862 - 1865. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fretier, A. Besse, A. Delwail, M. Garcia, F. Morel, V. Leprivey-Lorgeot, J. Wijdenes, V. Praloran, and J.-C. Lecron Cyclosporin A inhibition of macrophage colony-stimulating factor (M-CSF) production by activated human T lymphocytes J. Leukoc. Biol., February 1, 2002; 71(2): 289 - 294. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |